Table 1 Overview of patient characteristics
From: Outcome of carcinoid heart syndrome in patients enrolled in the SwissNet cohort
|  | All patients, n = 23 | Group Ab, n = 4 | Group B n = 12 | Group C n = 6 |
|---|---|---|---|---|
Sex, n (%) | ||||
 Female | 7 (30) | 1 (25) | 4 (33) | 2 (33) |
 Male | 16 (70) | 3 (75) | 8 (67) | 4 (67) |
Age at diagnosis, years | ||||
 Mean (SD) | 64 (10) | 74 (7) | 65 (10)* | 56 (7)* |
 Median (iqr; min; max) | 65 (15; 45; 80) | 76 (9; 64; 80) | 70 (15.5; 49; 78) | 60 (6; 45; 65) |
Death Certified, n (%) | ||||
 No | 8 (35) | 0 (0) | 6 (50) | 1 (17) |
 Yes | 15 (65) | 4 (100) | 6 (50) | 5 (83) |
Death tumor-related, n (%) | ||||
 Yes | 15 (100) | 4 (100) | 6 (100) | 5 (100) |
Time-to-death after NET diagnosis, monthsa | ||||
 Mean (SD) | 15 (21) | 3 (2) | 4 (6) | 47(9) |
 Median (iqr; min; max) | 3 (28; 0; 61.4) | 2 (2;1;6) | 0.4 (3;0;20) | 48 (12;28; 62) |
Time-to-death after diagnosis of CHD, monthsa | ||||
 Mean (SD) | 24 (25) | 7 (6) | 50 (18)* +  | 6 (6) |
 Median (iqr; min; max) | 16 (34; 0; 144) | 5 (6;1;16) | 49 (26;30;75) | 4 (2;0;17) |